Navigation Links
NYU Medical Center Collaborates With Rosetta Genomics to Develop a microRNA-Based Diagnostic Test for Melanoma
Date:9/7/2007

Various statements in this release concerning Rosetta's future expectations, plans and prospects, including without limitation, statements relating to our ability to successfully develop early detection diagnostic products for lung cancer and Melanoma in collaboration with NYU Medical Center, the role of miRNAs in human physiology and disease, and the potential of microRNAs in the diagnosis and treatment of disease, constitute forward-looking statements for the purposes of the safe harbor provisions under The Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those indicated by these forward-looking statements as a result of various important factors, including risks related to: Rosetta's approach to discover and develop novel diagnostics products, which is unproven and may never lead to marketable products; Rosetta's ability to fund and the results of further pre-clinical and clinical trials; obtaining, maintaining and protecting intellectual property utilized by Rosetta's products; Rosetta's ability to enforce its patents against infringers and to defend its patent portfolio against challenges from third parties; Rosetta's ability to obtain additional funding to support its business activities; Rosetta's dependence on third parties for development, manufacture, marketing, sales, and distribution of products; the successful development of Rosetta's product candidates, all of which are in early stages of development; obtaining regulatory approval for products; competition from others using technology similar to Rosetta's and others developing products for similar uses; Rosetta's dependence on collaborators; and Rosetta's short operating history; as well as those risks more fully discussed in the "Risk Factors" section of Rosetta's most recent Registration Statement on Form F-1 on file with the Securities and Exchange Commission. In addition, any forward-looking statements represent Rosetta's views only as of today and
'/>"/>

SOURCE Rosetta Genomics Ltd
Copyright©2007 PR Newswire.
All rights reserved

2

GOOD

Page: 1 2 3 4 5

Related biology technology :

1. Medical College receives $377K to study brain disease
2. Barriers will not stop convergence of medical technologies
3. Medical College team creates website for tracking flu
4. Biomedical engineering conference invites manufacturers
5. Visions: Wade offers straight talk on e-medical records
6. Merge unveils updated medical imaging software
7. Medical College receives $1.4M cancer grant
8. Medical technology firm lands $100K federal grant
9. Doyle outlines spending for Medical College, UWM
10. And the winners in medical design are
11. Manufacturing partnership will move into biotech and biomedical spaces
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... June 18, 2013   Lexicon Pharmaceuticals, Inc. ... company focused on discovering breakthrough treatments for human ... has joined the company as its vice president ... brings extensive commercial experience to Lexicon, including both ... of therapeutic areas. Mr. Northcott has ...
(Date:6/18/2013)... Though health care jobs continued to be added ... Labor Statistics -- the increase was far below the calendar ... care jobs were added in home health care and outpatient ... jobs. Overall, the U.S. unemployment rate stayed flat at 7.6 ... that a total of just over 36,000 job cuts were ...
(Date:6/18/2013)... 18, 2013 PathoGenetix, Inc. ... for rapid bacterial strain typing, announced today that ... company as Vice President of Engineering. Dr. Luckey ... company’s RESOLUTION™ Microbial Genotyping System . The ... instrument, pathogen-specific assay kits, database and software, will ...
(Date:6/18/2013)... June 18, 2013 On June 11, ... released a final decision memorandum concluding that FDG ... subsequent management of anti-tumor strategy, and the agency ... National Oncological PET Registry (NOPR) was developed jointly by ... projects under the Coverage with Evidence Development (CED) program ...
Breaking Biology Technology:John Northcott Joins Lexicon as Vice President of Marketing, Commercial Strategy and Operations 2John Northcott Joins Lexicon as Vice President of Marketing, Commercial Strategy and Operations 3MedZilla Employment Report for June 2013 -- Jobs in Health Care Grow, But at Slower Pace 2MedZilla Employment Report for June 2013 -- Jobs in Health Care Grow, But at Slower Pace 3PathoGenetix Hires Technology Development VP for Resolution Microbial Genotyping System 2PathoGenetix Hires Technology Development VP for Resolution Microbial Genotyping System 3WMIS Welcomes CMS Decision: Expanding Coverage for FDG-PET and Ending NOPR Data 2WMIS Welcomes CMS Decision: Expanding Coverage for FDG-PET and Ending NOPR Data 3
... IRVINE, Calif., Sept. 10 ISTA Pharmaceuticals, Inc. (Nasdaq: ... NewsMakers in the Biotech Industry Conference at 11:30 a.m. Eastern ... in New York, NY. , , ISTA,s ... Silvernail will provide an update on the Company,s commercial and ...
... Md., Sept. 10 Cylex, Inc., a venture-backed global ... in vitro diagnostic products intended to illuminate ... Brad L. Stewart, to chief executive officer and chairman ... in December 2007, Mr. Stewart has successfully led the ...
... , , , DALLAS, Sept. ... (OTC Bulletin Board: ACCP), provided an update today on the Company,s clinical development ... drug that has shown to be active in many ... team recently met with its partners Aosaikang Medicinal Group (ASK) ...
Cached Biology Technology:Cylex, Inc. Appoints Brad L. Stewart as Chief Executive Officer and Chairman of the Board 2Cylex, Inc. Appoints Brad L. Stewart as Chief Executive Officer and Chairman of the Board 3Cylex, Inc. Appoints Brad L. Stewart as Chief Executive Officer and Chairman of the Board 4Access Pharmaceuticals Provides Update on ProLindac(TM)Clinical Development Plan 2Access Pharmaceuticals Provides Update on ProLindac(TM)Clinical Development Plan 3Access Pharmaceuticals Provides Update on ProLindac(TM)Clinical Development Plan 4
(Date:6/17/2013)... CORVALLIS, Ore. Amphibian populations are declining worldwide and ... be spread by bullfrogs, but a two-year study shows ... suggestions that bullfrogs are a tolerant carrier host that ... frogs from eggs in controlled experimental conditions, they found ... dendrobatidis , also called Bd or a chytrid fungus, ...
(Date:6/17/2013)... in French . ... mice with Alzheimer,s disease can be reversed with treatment. The ... - The Neuro, at McGill University and at Universit de ... in the brain of mice with advanced Alzheimer,s disease (AD) ... Journal of Neuroinflammation in May, also suggest an ...
(Date:6/16/2013)... SAN FRANCISCO (June 16, 2013)Male mice who were fed ... to father offspring who also had higher levels of ... The effect was observed primarily in male offspring, despite ... at the annual meeting of The Endocrine Society in ... traits that may affect metabolism and behavior of offspring ...
Breaking Biology News(10 mins):Bullfrogs may help spread deadly amphibian fungus, but also die from it 2Blocking overactive receptor in Alzheimer's recovers memory loss and more 2Obese male mice father offspring with higher levels of body fat 2
... is a universal phenomenon that occurs in biological ... to population dynamics across thousands of kilometers. ... Synthesis (NIMBioS) is now accepting applications for its ... to be held April 11-13, 2011, at NIMBioS ...
... published in the journal Archives of Toxicology , ... in part caused by poorly-bound iron which causes the ... components of living systems. , These toxins, called hydroxyl ... parts of the body. , In order to protect ...
... antibiotic is consumed, researchers have learned that up to ... This means the drugs can leave the body almost ... of agricultural areas, excreted antibiotics can then enter stream ... discharges from animal feeding operations, fish hatcheries, and nonpoint ...
Cached Biology News:See off Alzheimer's with the color purple 2Virginia Tech engineer identifies new concerns for antibiotic resistance, pollution 2Virginia Tech engineer identifies new concerns for antibiotic resistance, pollution 3
... HM-4000 Multidizer is designed with a variety ... rotating - all in one unit. Shake, ... independently operating compartments allow for hybridization and ... motion , The upper chamber uses ...
... Jouan MSC series of Class II ... conditions and certification to the world's ... ensures that the cabinets cannot be ... Natural lighting, low noise and arm ...
... (for heat-labile and very volatile solvents) of ... applications of molecular biology and biochemistry for ... The RC systems can be expanded with ... wide selection of rotors (eliminating sample loss ...
... is a personal desktop unit ideal for use ... , Rotation speed set at 12 rpm ... C , Bottle capacity of four 35 ... ml conical ,plastic bottles , Consistent, repeatable ...
Biology Products: